As of 2025-09-16, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 32.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 152.24 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -78.6%.
The range of the Relative Valuation is (35.28) - 126.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 30.2x | 26.8x |
| Forward P/E multiples | 23.4x - 34.3x | 27.8x |
| Fair Price | (35.28) - 126.98 | 32.54 |
| Upside | -123.2% - -16.6% | -78.6% |
| Date | P/E |
| 2025-09-15 | -108.22 |
| 2025-09-12 | -108.68 |
| 2025-09-11 | -113.55 |
| 2025-09-10 | -108.96 |
| 2025-09-09 | -111.88 |
| 2025-09-08 | -115.16 |
| 2025-09-05 | -116.58 |
| 2025-09-04 | -115.38 |
| 2025-09-03 | -115.40 |
| 2025-09-02 | -114.63 |
| 2025-08-29 | -116.09 |
| 2025-08-28 | -116.03 |
| 2025-08-27 | -115.73 |
| 2025-08-26 | -116.38 |
| 2025-08-25 | -116.66 |
| 2025-08-22 | -115.05 |
| 2025-08-21 | -109.86 |
| 2025-08-20 | -113.44 |
| 2025-08-19 | -112.66 |
| 2025-08-18 | -111.59 |
| 2025-08-15 | -111.38 |
| 2025-08-14 | -110.75 |
| 2025-08-13 | -110.18 |
| 2025-08-12 | -108.59 |
| 2025-08-11 | -105.87 |
| 2025-08-08 | -105.73 |
| 2025-08-07 | -106.47 |
| 2025-08-06 | -106.87 |
| 2025-08-05 | -119.06 |
| 2025-08-04 | -119.37 |
| 2025-08-01 | -118.65 |
| 2025-07-31 | -120.59 |
| 2025-07-30 | -125.25 |
| 2025-07-29 | -126.85 |
| 2025-07-28 | -127.24 |
| 2025-07-25 | -125.77 |
| 2025-07-24 | -125.90 |
| 2025-07-23 | -119.39 |
| 2025-07-22 | -116.13 |
| 2025-07-21 | -106.48 |
| 2025-07-18 | -109.82 |
| 2025-07-17 | -111.39 |
| 2025-07-16 | -110.14 |
| 2025-07-15 | -109.77 |
| 2025-07-14 | -112.35 |
| 2025-07-11 | -113.31 |
| 2025-07-10 | -116.34 |
| 2025-07-09 | -113.01 |
| 2025-07-08 | -112.59 |
| 2025-07-07 | -109.40 |